自2013年以来,港股市场作为医疗服务企业的上市之地已经越来越成熟和活跃,逐渐在香港主板形成了医疗服务企业的板块效应。同时,与在港股上市的数量占多数的香港本地医疗服务企业相比,从融资规模、市值还是市盈率的角度来看,中国内地医疗服务企业在港股市场都是主力军,也是较为香港资本市场投资者认可的。本文对康华医疗、新世纪医疗、弘和仁爱医疗等中国医疗服务企业的港股上市进行解析,对其业务、上市架构、投资亮点及发行情况进行分析,并对医疗服务企业港股IPO重点关注问题进行简要介绍。
<<Since 2013,as the place where medical services companies go IPO,Hong Kong stock market have become more and more active and mature,gradually formed the plate effect of medical services companies in Hong Kong main board. At the same time,compared to the local Hong Kong medical services companies that took up the majority of the quantities of going IPO in Hong Kong stock market,from the view of financing scale,market value and price earnings ratio,medical services companies in mainland are the main force of Hong Kong stock market,and also have been recognized by investors in Hong Kong capital market. The passage analyzes the cases of Chinese medical services companies go IPO in Hong Kong stock market like Kanghua healthcare,New Century healthcare,Hongherenai healthcare,and analyzes their services,listing structure,investment highlights and issuing situation,as well as briefly introduce the problems that medical services companies Hong Kong stock IPO mainly focuses on.
<<